SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G - Statement of Beneficial Ownership by Certain Investors:
SEC Accession No. 0000921895-15-000430
Filing Date
2015-02-17
Accepted
2015-02-17 16:08:48
Documents
2

Document Format Files

Seq Description Document Type Size
1 SCHEDULE 13G sc13g07422vit_01232015.htm SC 13G 199780
2 JOINT FILING AGREEMENT ex991to13g07422vit_01232015.htm EX-99.1 29513
  Complete submission text file 0000921895-15-000430.txt   231055
Mailing Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104
Business Address 1 SANSOME ST 30TH FL SAN FRANCISCO CA 94104 3125066500
BIOTECHNOLOGY VALUE FUND L P (Filed by) CIK: 0000918923 (see all company filings)

IRS No.: 363924731 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G
SIC: 6282 Investment Advice

Mailing Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034
Business Address 502 WEST OFFICE CENTER DR FORT WASHINGTON PA 19034 215-461-2000
Vitae Pharmaceuticals, Inc (Subject) CIK: 0001157602 (see all company filings)

IRS No.: 000000000 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G | Act: 34 | File No.: 005-88337 | Film No.: 15622353
SIC: 2834 Pharmaceutical Preparations